{"id":"W3093489725","doi":"10.14309/01.ajg.0000706724.29564.0b","title":"S1169 Twelve-Month Interim Analysis of Efficacy and Safety of Givosiran, an Investigational RNAi Therapeutic for Acute Hepatic Porphyria, in the ENVISION Open Label Extension","year":2020,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Placebo; Porphobilinogen; Internal medicine; Gastroenterology; Clinical endpoint; Clinical trial; Pharmacology; Porphyria; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002691452,0.0009579211,0.002331064,0.0004938226,0.0003798762,0.0008327013,0.0005169496,0.001164162,0.008654489],"category_scores_gemma":[0.001897173,0.0003100951,0.001638886,0.0003216091,0.0006154176,0.0007560588,0.000318025,0.002262205,0.001491284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000525364,"about_ca_system_score_gemma":0.001061931,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000435463,"about_ca_topic_score_gemma":0.0007584101,"domain_scores_codex":[0.9991695,0.0003149492,0.00008043219,0.0001413971,0.0001153349,0.0001785259],"domain_scores_gemma":[0.9984829,0.0003803563,0.0003867434,0.0002173545,0.0001616354,0.0003710208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9073559,0.01727127,0.002797881,0.0004040358,0.0009088435,0.0001195671,0.00004722677,0.0008552583,0.01429296,0.0002158912,0.003605472,0.0521258],"study_design_scores_gemma":[0.3175724,0.6384319,0.02419692,0.00007629814,0.001407692,0.000251893,0.00005385618,0.002108745,0.009001297,0.0003438026,0.006506371,0.00004886388],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9795938,0.001753969,0.001494878,0.0004356106,0.0003193807,0.002912557,0.00677967,0.0002474009,0.006462766],"genre_scores_gemma":[0.9808475,0.0006100555,0.002308073,0.0005057463,0.0001727124,0.00301659,0.00664888,0.00003415411,0.005856293],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008654489,"threshold_uncertainty_score":0.02895212,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02898112285009389,"score_gpt":0.3241551702311172,"score_spread":0.2951740473810233,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}